These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy. Vajda FJ; O'Brien T; Lander C; Graham J; Eadie M Epilepsia; 2014 Aug; 55(8):1229-34. PubMed ID: 24995555 [TBL] [Abstract][Full Text] [Related]
23. Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam. Mula M; Trimble MR; Sander JW Epilepsia; 2007 Dec; 48(12):2322-6. PubMed ID: 17711462 [TBL] [Abstract][Full Text] [Related]
24. Subjective preference for lamotrigine or topiramate in healthy volunteers: relationship to cognitive and behavioral functioning. Werz MA; Schoenberg MR; Meador KJ; Loring DW; Ray PG; Kaul-Gupta R; Ogrocki P Epilepsy Behav; 2006 Feb; 8(1):181-91. PubMed ID: 16377253 [TBL] [Abstract][Full Text] [Related]
25. Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study. Peltola J; Peltola M; Auvinen A; Raitanen J; Fallah M; Keränen T Acta Neurol Scand; 2009 Jan; 119(1):55-60. PubMed ID: 18616622 [TBL] [Abstract][Full Text] [Related]
26. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. Labiner DM; Ettinger AB; Fakhoury TA; Chung SS; Shneker B; Tatum Iv WO; Mitchell Miller J; Vuong A; Hammer AE; Messenheimer JA Epilepsia; 2009 Mar; 50(3):434-42. PubMed ID: 19016830 [TBL] [Abstract][Full Text] [Related]
27. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study. Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM; J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362 [TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. Werhahn KJ; Trinka E; Dobesberger J; Unterberger I; Baum P; Deckert-Schmitz M; Kniess T; Schmitz B; Bernedo V; Ruckes C; Ehrlich A; Krämer G Epilepsia; 2015 Mar; 56(3):450-9. PubMed ID: 25684224 [TBL] [Abstract][Full Text] [Related]
29. Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease. Cumbo E; Ligori LD Epilepsy Behav; 2010 Apr; 17(4):461-6. PubMed ID: 20188634 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154 [TBL] [Abstract][Full Text] [Related]
31. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Meador KJ; Loring DW; Vahle VJ; Ray PG; Werz MA; Fessler AJ; Ogrocki P; Schoenberg MR; Miller JM; Kustra RP Neurology; 2005 Jun; 64(12):2108-14. PubMed ID: 15985582 [TBL] [Abstract][Full Text] [Related]
32. Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence. Cavitt J; Privitera M Arch Neurol; 2004 Oct; 61(10):1604-7. PubMed ID: 15477517 [TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacology of topiramate versus lamotrigine versus phenobarbital: comparison of efficacy and side effects using odds ratios. Lathers CM; Schraeder PL; Claycamp HG J Clin Pharmacol; 2003 May; 43(5):491-503. PubMed ID: 12751270 [TBL] [Abstract][Full Text] [Related]
34. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world. Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487 [TBL] [Abstract][Full Text] [Related]
35. A randomized, open-label, multicenter comparative trial of levetiracetam and topiramate as adjunctive treatment for patients with focal epilepsy in Korea. Lee SK; Lee SA; Kim DW; Loesch C; Pelgrims B; Osakabe T; Lee B; Epilepsy Behav; 2019 Aug; 97():67-74. PubMed ID: 31195326 [TBL] [Abstract][Full Text] [Related]
36. The teratogenicity of the newer antiepileptic drugs - an update. Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ Acta Neurol Scand; 2014 Oct; 130(4):234-8. PubMed ID: 25040242 [TBL] [Abstract][Full Text] [Related]
37. Retention rate of levetiracetam in children with intractable epilepsy at 1 year. Peake D; Mordekar S; Gosalakkal J; Mukhtyar B; Buch S; Crane J; Wheway R; Rittey C; Donnelly J; Whitehouse WP; Philip S Seizure; 2007 Mar; 16(2):185-9. PubMed ID: 17258474 [TBL] [Abstract][Full Text] [Related]
38. Adverse reactions of Topiramate and Lamotrigine in children. Shechter T; Shorer Z; Kramer U; Lerman-Sagie T; Ronen E; Rotem R; Gorodischer R Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):187-92. PubMed ID: 15517533 [TBL] [Abstract][Full Text] [Related]
39. Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy. Huang CW; Pai MC; Tsai JJ Psychiatry Clin Neurosci; 2008 Oct; 62(5):548-53. PubMed ID: 18950374 [TBL] [Abstract][Full Text] [Related]
40. Lack of an effect of topiramate on lamotrigine serum concentrations. Berry DJ; Besag FM; Pool F; Natarajan J; Doose D Epilepsia; 2002 Aug; 43(8):818-23. PubMed ID: 12180999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]